We are live on
!
Find out more
Achieve Life Sciences
ACHV
ACHV
60 hedge funds and large institutions have $77.5M invested in Achieve Life Sciences in 2013 Q2 according to their latest regulatory filings, with 60 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
95% less call options, than puts
Call options by funds: $181K | Put options by funds: $3.38M
Holders
60
Holders Change
+60
Holders Change %
–
% of All Funds
1.96%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
60
Increased
–
Reduced
–
Closed
–
Calls
$181K
Puts
$3.38M
Net Calls
-$3.19M
Net Calls Change
-$3.19M
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Citigroup
New York
| $96K | +$89.5K | +4 | New |
|
|
BA
52
BlackRock Advisors
Wilmington,
Delaware
| $94K | +$89.5K | +4 | New |
|
53
Group One Trading
Chicago,
Illinois
| $56K | +$67.1K | +3 | New |
|
54
Barclays
London,
United Kingdom
| $51K | +$44.7K | +2 | New |
|
|
PCM
55
Prelude Capital Management
New York
| $49K | +$44.7K | +2 | New |
|
|
TRCT
56
Tower Research Capital (TRC)
New York
| $47K | +$44.7K | +2 | New |
|
57
AllianceBernstein
Nashville,
Tennessee
| $41K | +$44.7K | +2 | New |
|
|
ST
58
Stifel Trust
St. Louis,
Missouri
| $40K | +$44.7K | +2 | New |
|
59
Ameriprise
Minneapolis,
Minnesota
| $17K | +$22.4K | +1 | New |
|
|
GT
60
Glenmede Trust
Philadelphia,
Pennsylvania
| $10K | +$22.4K | +1 | New |
|
61
BlackRock
New York
| $5K | – | – | – |
|
|
U
62
UBS
Zurich,
Switzerland
| $2K | – | – | – |
|
|
VCM
63
Vigilant Capital Management
Portland,
Maine
| $2K | – | – | – |
|
ACHV Hedge Fund Activity: Q2 2013 in Review
60 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q2 2013, worth a combined $77.5M.
Buyers outnumbered sellers: 60 funds opened new ACHV positions and 0 closed out — a net gain of 60 holders — while 0 added to existing stakes and 0 trimmed.
- 60 institutional investors held Achieve Life Sciences (ACHV) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $77.5M of Achieve Life Sciences stock for Q2 2013.
- 60 funds opened new Achieve Life Sciences positions in Q2 2013 and 0 closed out, a net change of +60 holders.
Based on aggregated 13F filings for Q2 2013.